BRIEF published on 10/22/2024 at 08:35, 30 days 4 hours ago ARCHOS : Croissance du Chiffre d'Affaires de 112% au 3e Trimestre 2024 Croissance Financière Dispositifs Médicaux Archos Solutions Mobiles Tablettes Électroniques
PRESS RELEASE published on 10/22/2024 at 08:30, 30 days 4 hours ago Forte croissance du chiffre d'affaires à fin septembre 2024 : +112% Le groupe ARCHOS affiche une croissance de 112% avec un CA de 23,5 M€ au T3 2024, grâce à l'intégration d'Elexo. Projets dans la défense, dispositifs médicaux connectés et électronique grand public Croissance Dispositifs Médicaux Electronique Grand Public Archos Solutions Mobiles
BRIEF published on 08/27/2024 at 17:50, 2 months 24 days ago POLADERME nominated for the “Best start-up” prize from the Galien Foundation Innovation Health Poladerme Galien Foundation Best Start-up Award
BRIEF published on 08/27/2024 at 17:50, 2 months 24 days ago POLADERME nominée au prix "Best start-up" de la Fondation Galien Innovation Santé Poladerme Fondation Galien Prix Best Start-up
PRESS RELEASE published on 08/27/2024 at 17:45, 2 months 24 days ago POLADERME est nominée au prix " Best start-up " de la fondation Galien ARCHOS annonce que sa filiale POLADERME a été nominée au prix 'Best start-up' de la Fondation Galien, renommée mondiale pour honorer les innovateurs en sciences de la vie Innovation Start-up Archos Poladerme Prix Galien
BRIEF published on 08/07/2024 at 18:05, 3 months 13 days ago ARCHOS: 90% growth in turnover and return to profitability Financial Results Medical Devices Growth Archos LOGIC INSTRUMENT
BRIEF published on 08/07/2024 at 18:05, 3 months 13 days ago ARCHOS : croissance de 90% du chiffre d'affaires et retour à la profitabilité Résultats Financiers Croissance Dispositifs Médicaux Archos LOGIC INSTRUMENT
PRESS RELEASE published on 08/07/2024 at 18:00, 3 months 13 days ago Groupe ARCHOS : hyper croissance du chiffre d'affaires, résultat opérationnel et résultat net positifs ARCHOS réalise une croissance exceptionnelle de 90% au premier semestre 2024 grâce à l'intégration réussie d'Elexo. Le Résultat d'exploitation confirme le retour à la profitabilité Croissance Profitabilité Archos Résultat D'exploitation Elexo
BRIEF published on 07/16/2024 at 17:50, 4 months 4 days ago ARCHOS Group: Hyper Growth in turnover in the first half of 2024 Medical Devices Growth Turnover Archos Mobile Solutions
BRIEF published on 07/16/2024 at 17:50, 4 months 4 days ago Groupe ARCHOS : Hyper Croissance du chiffre d'affaires au premier semestre 2024 Chiffre D'affaires Croissance Dispositifs Médicaux Archos Solutions Mobiles
Published on 11/21/2024 at 13:00, 12 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 12 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 12 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 12 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 12 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 37 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 57 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 42 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 14 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 14 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 14 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 5 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 52 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
